Nath Bio-Genes Falls 6.60% Amid Earnings Decline and Rising Interest Costs
2026-11-21 16:07:04Key Events This Week Nov 16: Sharp quarterly profit decline reported, signalling negative trend shift Nov 16: MarketsMOJO upgrades rating from Strong Sell to Sell on technical improvement Nov 20: Week closes at Rs.133.05, down 6.60% despite Sensex gains Week OpenRs.142.45 Week CloseRs.133.05-6.60%<...
Read More
Nath Bio-Genes Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift
2026-11-16 13:00:31Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has reported a marked deterioration in its financial trend for the quarter ended September 2026. The company’s financial trend score has plunged from a positive 5 to a negative -13 over the past three months, signalling a shift from stability to contraction in key performance metrics including revenue and profitability.
Read More
Nath Bio-Genes (India) Ltd is Rated Strong Sell
2026-11-04 10:11:29Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 November 2026, providing investors with the latest perspective on the company’s performance and prospects.
Read More
Nath Bio-Genes (India) Ltd is Rated Strong Sell
2026-10-24 10:10:39Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 24 October 2026, providing investors with the latest comprehensive view of the company’s position.
Read More
Nath Bio-Genes (India) Ltd is Rated Strong Sell
2026-10-13 10:10:56Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Nath Bio-Genes (India) Ltd is Rated Strong Sell
2026-10-02 10:10:44Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a shift from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 October 2026, providing investors with an up-to-date view of the stock's position.
Read More
Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-09-21 08:11:54Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Sep 2026. This shift reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and valuation concerns, signalling heightened caution for investors amid persistent underperformance against benchmarks.
Read More
Nath Bio-Genes Forms Death Cross, Signalling Potential Bearish Trend
2026-09-18 18:00:22Nath Bio-Genes (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action.
Read More
Nath Bio-Genes (India) Ltd is Rated Sell
2026-09-11 10:10:22Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreTranscript
17-Nov-2026 | Source : BSEAudio Transcript of Conference Call held on 16th November 2026
Announcement under Regulation 30 (LODR)-Investor Presentation
16-Nov-2026 | Source : BSEPresentation on Unaudited Financial Results as of 30th September 2026
Financial Results - Outcome Of Board Meeting
14-Nov-2026 | Source : BSEUnaudited Standalone and Consolidated Financial Results as on 30th September 2026
Corporate Actions
No Upcoming Board Meetings
Nath Bio-Genes (India) Ltd has declared 20% dividend, ex-date: 11 Sep 26
No Splits history available
No Bonus history available
No Rights history available